» Articles » PMID: 18818173

An Integrated Intervention Program to Control Diabetes in Overweight Chinese Women and Men with Type 2 Diabetes

Overview
Date 2008 Sep 27
PMID 18818173
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

This study evaluated a structured and integrated intervention program on diabetes management in individuals with type 2 diabetes in Shanghai, China. Men and women with type 2 diabetes and body mass index > 23 kg/m2 were randomized into a 24-week, prospective, randomized clinical trial. The Reference Group (n=50) received diabetes education including diet and physical activity instruction only; the Intervention Group (n=100) received more intensive intervention, including diabetes education with frequent blood glucose monitoring, nutritional counseling, meal plans with diabetes-specific nutritional meal replacement, and weekly progress updates with study staff. Major study assessments were obtained at baseline, and after 12 and/or 24 weeks of intervention. The Intervention Group improved fasting blood glucose, insulin, systolic and diastolic blood pressures compared to Reference Group ( p <0.05). Importantly, HbA1c was lower ( p <0.001) in the Intervention Group at 12 weeks (-0.6 +/- 0.1%) and 24 weeks (-0.8 +/- 0.1%). Weight loss was modest, but significant differences were observed between groups ( p <0.05). Weight change from baseline after 12 and 24 weeks was -2.8 +/- 0.2% and -3.7 +/- 0.3%, respectively, in the Intervention Group vs -1.8 +/- 0.4% and -2.5 +/- 0.4% in the Reference Group. Additionally, waist and hip circumferences and waist:hip ratio decreased in the Intervention compared to the Reference Group ( p <0.05). In conclusion, this study demonstrates that Chinese men and women with type 2 diabetes following an integrated intervention program including diabetes education, frequent blood glucose monitoring and daily use of a diabetes-specific meal replacement, can achieve significant improvements in glycemic control and markers of cardiovascular health.

Citing Articles

Meal replacements on obesity and leptin: a systematic review and meta-analysis.

Fatahi S, Fotros D, Sohouli M, Vahidshahi K, Rohani P, Guimaraes N Rev Endocr Metab Disord. 2024; 26(1):55-80.

PMID: 39433654 DOI: 10.1007/s11154-024-09918-5.


Diabetes-specific formula with standard of care improves glycemic control, body composition, and cardiometabolic risk factors in overweight and obese adults with type 2 diabetes: results from a randomized controlled trial.

Tey S, Chee W, Deerochanawong C, Berde Y, Lim L, Boonyavarakul A Front Nutr. 2024; 11:1400580.

PMID: 39077157 PMC: 11285196. DOI: 10.3389/fnut.2024.1400580.


Transcultural Lifestyle Medicine in Type 2 Diabetes Care: Narrative Review of the Literature.

Gonzalez-Rivas J, Pavlovska I, Polcrova A, Nieto-Martinez R, Mechanick J Am J Lifestyle Med. 2023; 17(4):518-559.

PMID: 37426734 PMC: 10328213. DOI: 10.1177/15598276221095048.


Quality improvement strategies for diabetes care: Effects on outcomes for adults living with diabetes.

Konnyu K, Yogasingam S, Lepine J, Sullivan K, Alabousi M, Edwards A Cochrane Database Syst Rev. 2023; 5:CD014513.

PMID: 37254718 PMC: 10233616. DOI: 10.1002/14651858.CD014513.


Development of core outcome sets of Food for Special Medical Purposes designed for type 2 diabetes mellitus: a study protocol.

Mu D, Gong J, Wei Y, Chen M, Yu J, Du L Trials. 2023; 24(1):223.

PMID: 36959627 PMC: 10037765. DOI: 10.1186/s13063-023-07214-2.